BSI and Poseidon to Collaborate on Global Good Distribution Practice Compliance Program for Medicines and Vaccines

BSI, a business improvement and standards company, announced a collaborative partnership with Poseidon, an independent pharmaceutical logistics network, with the objective of bringing greater quality, and certainty to the global distribution of medicines and vaccines.

BSI and Poseidon will bring their joint resources and expertise together to develop and execute a Multi-modal Compliance and Standards (MMCS) program to promote, monitor and assess adherence to the GDP (Good Distribution Practice) regulations that underpin global pharmaceutical logistics. The development of standards and the furtherance of assessment and training will form part of the program scope.

"The respective strengths of BSI and Poseidon will combine to produce a collaborative, industry-wide GDP compliance capability that is designed to bring best practice to this industry", explains Courtney Soulsby, Sector Development Director, Healthcare at BSI. "BSI, as a global business improvement and standards company and a Royal Charter organization, seeks to facilitate and enhance pharmaceutical industry quality distribution practices. The new program will provide a wide range of standards guidance, support and assessment covering all aspects of GDP compliance including quality assurance, risk-management, cold-chain best-practice, training, and standards."

Alan Kennedy, Executive Director at Poseidon stresses, "The strict impartiality and independence of both BSI and Poseidon is absolutely fundamental to the objectivity of the program and in securing the support and patronage of shippers, regulators and the rest of the stakeholders in the value chain.”.

According to Angus Metcalfe, BSI’s Managing Director, Global Healthcare: "The entire pharma-logistics industry stands to gain from this joined-up initiative which will reduce compliance costs, extract more value from logistics and lead to greater process and technical harmonization. It has the potential to be a game-changer for raising standards".

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!

  • <<
  • >>

Join the Discussion